The use of AAV vectors to knockdown KMT2D and YBX1 in the mammary glands of MMTV‐PyMT transgenic (MMTV‐KMT2D‐KD or MMTV‐YBX1‐KD) mice enabled us to test their therapeutic potential in breast cancer. This evidence concerns the gene KMT2D and breast cancer.